CD44 + /CD24 - Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study.
Unedo Hence Markus SihombingAndrijono AndrijonoGatot PurwotoSupriadi GandamihardjaAlida R HarahapPrimariadewi RustamadjiAria KekalihRetno WidyawatiDzicky Rifqi FuadyPublished in: Journal of the Egyptian National Cancer Institute (2022)
We conclude that there is a substantial association between high CSCs expression and chemoresistance in ovarian cancer and that CSCs immunohistochemistry has a higher predictive value.